Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Snyder

Showing results (931-940 of 954) with videos related to

Pageof 96
Sort By:
Hepatology (Baltimore, Md.)|June 24, 2026
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver diseaseDerek D Satre, Leila Taj, Robert J Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2024
Perpendicular crossing chains enable high mobility in a noncrystalline conjugated polymerJack F Coker, Stefania Moro, Anders S Gertsen, et al.
Nature Communications|December 15, 2022
Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnosticAnna Nemudraia, Artem Nemudryi, Murat Buyukyoruk, et al.
British Journal of Cancer|November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancerJ Bernhard, D Zahrieh, A S Coates, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2024
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver DiseaseDerek D Satre, Dhweeja Dasarathy, Steven L Batki, et al.
Alcohol, Clinical & Experimental Research|December 4, 2024
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosisJeremy W Luk, Nghiem B Ha, Amy M Shui, et al.
Molecular Cancer Therapeutics|September 5, 2024
Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in CancerRobinson Triboulet, Khikmet Sadykov, Darren M Harvey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceG Berclaz, S Li, K N Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2018
Mechanism of selective benzene hydroxylation catalyzed by iron-containing zeolitesBenjamin E R Snyder, Max L Bols, Hannah M Rhoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer GroupH Mouridsen, M Gershanovich, Y Sun, et al.
Pageof 96

Showing results (931-940 of 954) with videos related to

Sort By:
Pageof 96
Hepatology (Baltimore, Md.)|June 24, 2026
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver diseaseDerek D Satre, Leila Taj, Robert J Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2024
Perpendicular crossing chains enable high mobility in a noncrystalline conjugated polymerJack F Coker, Stefania Moro, Anders S Gertsen, et al.
Nature Communications|December 15, 2022
Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnosticAnna Nemudraia, Artem Nemudryi, Murat Buyukyoruk, et al.
British Journal of Cancer|November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancerJ Bernhard, D Zahrieh, A S Coates, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2024
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver DiseaseDerek D Satre, Dhweeja Dasarathy, Steven L Batki, et al.
Alcohol, Clinical & Experimental Research|December 4, 2024
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosisJeremy W Luk, Nghiem B Ha, Amy M Shui, et al.
Molecular Cancer Therapeutics|September 5, 2024
Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in CancerRobinson Triboulet, Khikmet Sadykov, Darren M Harvey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceG Berclaz, S Li, K N Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2018
Mechanism of selective benzene hydroxylation catalyzed by iron-containing zeolitesBenjamin E R Snyder, Max L Bols, Hannah M Rhoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer GroupH Mouridsen, M Gershanovich, Y Sun, et al.
Pageof 96